Progeria - the old children
DOI:
https://doi.org/10.12775/QS.2024.15.52452Keywords
progeria, old, children, agingAbstract
Introduction and Purpose: Progeria, also known as Hutchinson-Gilford progeria syndrome, is a rare genetic disorder characterized by accelerated aging in children. This research article aims to provide a comprehensive overview of progeria, including its etiology, symptoms, diagnosis, and treatment options. By synthesizing existing knowledge, this study seeks to enhance understanding and promote effective management strategies for individuals affected by this condition.
Description of the State of Knowledge: Progeria is an exceedingly rare genetic disorder, with an estimated incidence of approximately one in every 4 to 8 million births worldwide. It manifests early in childhood, leading to premature aging and a spectrum of associated health complications. The condition is primarily caused by a mutation in the LMNA gene, resulting in the production of a defective form of the protein lamin A. This abnormal protein disrupts the structural integrity of the cell nucleus, contributing to the characteristic features of progeria. Despite advances in medical research, there is currently no cure for progeria, and treatment options focus on managing symptoms and improving quality of life.
Summary: This research article provides a comprehensive overview of progeria, highlighting its genetic basis, clinical manifestations, diagnostic criteria, and therapeutic interventions. By elucidating the state of knowledge surrounding progeria, this study aims to facilitate early detection, enhance medical care, and foster ongoing research efforts aimed at advancing treatment modalities for affected individuals.
References
Ahmed MS, Ikram S, Bibi N, Mir A. Hutchinson-Gilford Progeria Syndrome: A Premature Aging Disease. Mol Neurobiol. 2018 May;55(5):4417-4427. doi: 10.1007/s12035-017-0610-7. Epub 2017 Jun 28. PMID: 28660486.
Ullrich NJ, Gordon LB. Hutchinson-Gilford progeria syndrome. Handb Clin Neurol. 2015;132:249-64. doi: 10.1016/B978-0-444-62702-5.00018-4. PMID: 26564085.
Koblan LW, Erdos MR, Wilson C, Cabral WA, Levy JM, Xiong ZM, Tavarez UL, Davison LM, Gete YG, Mao X, Newby GA, Doherty SP, Narisu N, Sheng Q, Krilow C, Lin CY, Gordon LB, Cao K, Collins FS, Brown JD, Liu DR. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice. Nature. 2021 Jan;589(7843):608-614. doi: 10.1038/s41586-020-03086-7. Epub 2021 Jan 6. PMID: 33408413; PMCID: PMC7872200.
Gonzalo S, Kreienkamp R, Askjaer P. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations. Ageing Res Rev. 2017 Jan;33:18-29. doi: 10.1016/j.arr.2016.06.007. Epub 2016 Jun 29. PMID: 27374873; PMCID: PMC5195863.
Mozzini C. Progeria, atherosclerosis and clonal hematopoiesis: links and future perspectives. Mech Ageing Dev. 2020 Dec;192:111365. doi: 10.1016/j.mad.2020.111365. Epub 2020 Sep 29. PMID: 33007346.
Kreienkamp R, Gonzalo S. Hutchinson-Gilford Progeria Syndrome: Challenges at Bench and Bedside. Subcell Biochem. 2019;91:435-451. doi: 10.1007/978-981-13-3681-2_15. PMID: 30888661.
Rahman MM, Ferdous KS, Ahmed M, Islam MT, Khan MR, Perveen A, Ashraf GM, Uddin MS. Hutchinson-Gilford Progeria Syndrome: An Overview of the Molecular Mechanism, Pathophysiology and Therapeutic Approach. Curr Gene Ther. 2021;21(3):216-229. doi: 10.2174/1566523221666210303100805. PMID: 33655857.
Xu S, Jin ZG. Hutchinson-Gilford Progeria Syndrome: Cardiovascular Pathologies and Potential Therapies. Trends Biochem Sci. 2019 Jul;44(7):561-564. doi: 10.1016/j.tibs.2019.03.010. Epub 2019 Apr 26. PMID: 31036409.
Guilbert SM, Cardoso D, Lévy N, Muchir A, Nissan X. Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing. Methods. 2021 Jun;190:3-12. doi: 10.1016/j.ymeth.2020.04.005. Epub 2020 Apr 9. PMID: 32278808.
Sharma A, Swarnkar B, Sethuraman G. Hutchinson-Gilford progeria. BMJ Case Rep. 2023 Sep 18;16(9):e256203. doi: 10.1136/bcr-2023-256203. PMID: 37723091; PMCID: PMC10510932.
Talukder P, Saha A, Roy S, Ghosh G, Dutta Roy D, Barua S. Progeria-a Rare Genetic Condition with Accelerated Ageing Process. Appl Biochem Biotechnol. 2023 Apr;195(4):2587-2596. doi: 10.1007/s12010-021-03514-y. Epub 2022 Apr 21. PMID: 35445924.
Sinha JK, Ghosh S, Raghunath M. Progeria: a rare genetic premature ageing disorder. Indian J Med Res. 2014 May;139(5):667-74. PMID: 25027075; PMCID: PMC4140030.
Piekarowicz K, Machowska M, Dzianisava V, Rzepecki R. Hutchinson-Gilford Progeria Syndrome-Current Status and Prospects for Gene Therapy Treatment. Cells. 2019 Jan 25;8(2):88. doi: 10.3390/cells8020088. PMID: 30691039; PMCID: PMC6406247.
Kreienkamp R, Gonzalo S. Metabolic Dysfunction in Hutchinson-Gilford Progeria Syndrome. Cells. 2020 Feb 8;9(2):395. doi: 10.3390/cells9020395. PMID: 32046343; PMCID: PMC7072593.
Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003 May 15;423(6937):293-8. doi: 10.1038/nature01629. Epub 2003 Apr 25. PMID: 12714972; PMCID: PMC10540076.
Badame AJ. Progeria. Arch Dermatol. 1989 Apr;125(4):540-4. PMID: 2649013.
Saxena S, Shukla D. The pursuit of therapy for progeria. Aging (Albany NY). 2021 Jun 27;13(12):15697-15698. doi: 10.18632/aging.203254. Epub 2021 Jun 27. PMID: 34176790; PMCID: PMC8266361.
Harhouri K, Frankel D, Bartoli C, Roll P, De Sandre-Giovannoli A, Lévy N. An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome. Nucleus. 2018 Jan 1;9(1):246-257. doi: 10.1080/19491034.2018.1460045. PMID: 29619863; PMCID: PMC5973194.
Cisneros B, García-Aguirre I, De Ita M, Arrieta-Cruz I, Rosas-Vargas H. Hutchinson-Gilford Progeria Syndrome: Cellular Mechanisms and Therapeutic Perspectives. Arch Med Res. 2023 Jul;54(5):102837. doi: 10.1016/j.arcmed.2023.06.002. Epub 2023 Jun 28. PMID: 37390702.
Benedicto I, Chen X, Bergo MO, Andrés V. Progeria: a perspective on potential drug targets and treatment strategies. Expert Opin Ther Targets. 2022 May;26(5):393-399. doi: 10.1080/14728222.2022.2078699. Epub 2022 May 19. PMID: 35575136.
Villa-Bellosta R. New treatments for progeria. Aging (Albany NY). 2019 Dec 22;11(24):11801-11802. doi: 10.18632/aging.102626. Epub 2019 Dec 22. PMID: 31866585; PMCID: PMC6949067.
Lian J, Du L, Li Y, Yin Y, Yu L, Wang S, Ma H. Hutchinson-Gilford progeria syndrome: Cardiovascular manifestations and treatment. Mech Ageing Dev. 2023 Dec;216:111879. doi: 10.1016/j.mad.2023.111879. Epub 2023 Oct 11. PMID: 37832833.
Batista NJ, Desai SG, Perez AM, Finkelstein A, Radigan R, Singh M, Landman A, Drittel B, Abramov D, Ahsan M, Cornwell S, Zhang D. The Molecular and Cellular Basis of Hutchinson-Gilford Progeria Syndrome and Potential Treatments. Genes (Basel). 2023 Feb 27;14(3):602. doi: 10.3390/genes14030602. PMID: 36980874; PMCID: PMC10048386.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dawid Dziedziński, Dawid Łoś, Aleksandra Nowak, Anita Janus, Agata Kaptur
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 130
Number of citations: 0